Cargando…

Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment

BACKGROUND: In general, prognosis and impact of prognostic/predictive factors are assessed with Kaplan-Meier plots and/or the Cox proportional hazard model. There might be substantive differences from the results using these models for the same patients, if different statistical methods were used, f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Patricia, Chapman, Judith-Anne W, Yu, Edward, Jones, Dennie, Yu, Changhong, Yuan, Fei, Sang-Joon, Lee
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805760/
https://www.ncbi.nlm.nih.gov/pubmed/17311683
http://dx.doi.org/10.1186/1471-2407-7-31
_version_ 1782132494050525184
author Tai, Patricia
Chapman, Judith-Anne W
Yu, Edward
Jones, Dennie
Yu, Changhong
Yuan, Fei
Sang-Joon, Lee
author_facet Tai, Patricia
Chapman, Judith-Anne W
Yu, Edward
Jones, Dennie
Yu, Changhong
Yuan, Fei
Sang-Joon, Lee
author_sort Tai, Patricia
collection PubMed
description BACKGROUND: In general, prognosis and impact of prognostic/predictive factors are assessed with Kaplan-Meier plots and/or the Cox proportional hazard model. There might be substantive differences from the results using these models for the same patients, if different statistical methods were used, for example, Boag log-normal (cure-rate model), or log-normal survival analysis. METHODS: Cohort of 244 limited-stage small-cell lung cancer patients, were accrued between 1981 and 1998, and followed to the end of 2005. The endpoint was death with or from lung cancer, for disease-specific survival (DSS). DSS at 1-, 3- and 5-years, with 95% confidence limits, are reported for all patients using the Boag, Kaplan-Meier, Cox, and log-normal survival analysis methods. Factors with significant effects on DSS were identified with step-wise forward multivariate Cox and log-normal survival analyses. Then, DSS was ascertained for patients with specific characteristics defined by these factors. RESULTS: The median follow-up of those alive was 9.5 years. The lack of events after 1966 days precluded comparison after 5 years. DSS assessed by the four methods in the full cohort differed by 0–2% at 1 year, 0–12% at 3 years, and 0–1% at 5 years. Log-normal survival analysis indicated DSS of 38% at 3 years, 10–12% higher than with other methods; univariate 95% confidence limits were non-overlapping. Surgical resection, hemoglobin level, lymph node involvement, and superior vena cava (SVC) obstruction significantly impacted DSS. DSS assessed by the Cox and log-normal survival analysis methods for four clinical risk groups differed by 1–6% at 1 year, 15–26% at 3 years, and 0–12% at 5 years; multivariate 95% confidence limits were overlapping in all instances. CONCLUSION: Surgical resection, hemoglobin level, lymph node involvement, and superior vena cava (SVC) obstruction all significantly impacted DSS. Apparent DSS for patients was influenced by the statistical methods of assessment. This would be clinically relevant in the development or improvement of clinical management strategies.
format Text
id pubmed-1805760
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18057602007-03-13 Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment Tai, Patricia Chapman, Judith-Anne W Yu, Edward Jones, Dennie Yu, Changhong Yuan, Fei Sang-Joon, Lee BMC Cancer Research Article BACKGROUND: In general, prognosis and impact of prognostic/predictive factors are assessed with Kaplan-Meier plots and/or the Cox proportional hazard model. There might be substantive differences from the results using these models for the same patients, if different statistical methods were used, for example, Boag log-normal (cure-rate model), or log-normal survival analysis. METHODS: Cohort of 244 limited-stage small-cell lung cancer patients, were accrued between 1981 and 1998, and followed to the end of 2005. The endpoint was death with or from lung cancer, for disease-specific survival (DSS). DSS at 1-, 3- and 5-years, with 95% confidence limits, are reported for all patients using the Boag, Kaplan-Meier, Cox, and log-normal survival analysis methods. Factors with significant effects on DSS were identified with step-wise forward multivariate Cox and log-normal survival analyses. Then, DSS was ascertained for patients with specific characteristics defined by these factors. RESULTS: The median follow-up of those alive was 9.5 years. The lack of events after 1966 days precluded comparison after 5 years. DSS assessed by the four methods in the full cohort differed by 0–2% at 1 year, 0–12% at 3 years, and 0–1% at 5 years. Log-normal survival analysis indicated DSS of 38% at 3 years, 10–12% higher than with other methods; univariate 95% confidence limits were non-overlapping. Surgical resection, hemoglobin level, lymph node involvement, and superior vena cava (SVC) obstruction significantly impacted DSS. DSS assessed by the Cox and log-normal survival analysis methods for four clinical risk groups differed by 1–6% at 1 year, 15–26% at 3 years, and 0–12% at 5 years; multivariate 95% confidence limits were overlapping in all instances. CONCLUSION: Surgical resection, hemoglobin level, lymph node involvement, and superior vena cava (SVC) obstruction all significantly impacted DSS. Apparent DSS for patients was influenced by the statistical methods of assessment. This would be clinically relevant in the development or improvement of clinical management strategies. BioMed Central 2007-02-20 /pmc/articles/PMC1805760/ /pubmed/17311683 http://dx.doi.org/10.1186/1471-2407-7-31 Text en Copyright © 2007 Tai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tai, Patricia
Chapman, Judith-Anne W
Yu, Edward
Jones, Dennie
Yu, Changhong
Yuan, Fei
Sang-Joon, Lee
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
title Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
title_full Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
title_fullStr Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
title_full_unstemmed Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
title_short Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
title_sort disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805760/
https://www.ncbi.nlm.nih.gov/pubmed/17311683
http://dx.doi.org/10.1186/1471-2407-7-31
work_keys_str_mv AT taipatricia diseasespecificsurvivalforlimitedstagesmallcelllungcanceraffectedbystatisticalmethodofassessment
AT chapmanjudithannew diseasespecificsurvivalforlimitedstagesmallcelllungcanceraffectedbystatisticalmethodofassessment
AT yuedward diseasespecificsurvivalforlimitedstagesmallcelllungcanceraffectedbystatisticalmethodofassessment
AT jonesdennie diseasespecificsurvivalforlimitedstagesmallcelllungcanceraffectedbystatisticalmethodofassessment
AT yuchanghong diseasespecificsurvivalforlimitedstagesmallcelllungcanceraffectedbystatisticalmethodofassessment
AT yuanfei diseasespecificsurvivalforlimitedstagesmallcelllungcanceraffectedbystatisticalmethodofassessment
AT sangjoonlee diseasespecificsurvivalforlimitedstagesmallcelllungcanceraffectedbystatisticalmethodofassessment